Our research encompasses the discovery, development and evaluation of biologics, particularly monoclonal antibodies, and small molecule drugs for global health challenges.

We use state-of-the-art biologics discovery technologies to identify novel biologics that are then tested for specificity and neutralising efficacy using functional assays.

Our aim is to develop new therapeutic and diagnostic tools to alleviate the burden of Neglected Tropical Diseases and other global health challenges.